tiprankstipranks
Trending News
More News >
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market
Advertisement

Oncopeptides AB (ONCO) Financial Statements

Compare
6 Followers

Oncopeptides AB Financial Overview

Oncopeptides AB's market cap is currently kr1.36B. The company's EPS TTM is kr-0.28; its P/E ratio is ―; Oncopeptides AB is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in SEK

Oncopeptides AB Earnings and Revenue History

Oncopeptides AB Debt to Assets

Oncopeptides AB Cash Flow

Oncopeptides AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis